Nexortest Technologies | Your Gateway to Global Market Entry

India CDSCO Medical Device Registration & Licensing Consultant

Navigate India's CDSCO regulatory framework with confidence. NexorTest Technologies provides end-to-end medical device registration consulting — from device classification and documentation to SUGAM portal submission and license issuance — for Class A through Class D devices, IVDs, and SaMD.

Devices Registered
0 +
First-Pass Approval
0 %
Years Experience
0 +
Regulatory Markets
0 +
Free CDSCO Assessment

Get a personalised regulatory roadmap in 24 hours

No obligation. Response within 24 hours.

India CDSCO Medical Device Registration & Licensing Consultant

Navigate India's CDSCO regulatory framework with confidence. NexorTest Technologies provides end-to-end medical device registration consulting — from device classification and documentation to SUGAM portal submission and license issuance — for Class A through Class D devices, IVDs, and SaMD.

Devices Registered
0 +
First-Pass Approval
0 %
Years Experience
0 +
Regulatory Markets
0 +
Free CDSCO Assessment

Get a personalised regulatory roadmap in 24 hours

CDSCO Classification Pathways

Four Risk-Based Device Classes Under MDR 2017

CDSCO classifies all medical devices into four risk categories. Your device class determines the registration pathway, documentation requirements, and review timeline.

Class A — Low Risk
Class A Devices

Lowest-risk devices including tongue depressors, bandages, examination gloves, and reusable surgical instruments. Non-sterile, non-measuring Class A devices can be self-notified.

How is Class A registration different?

Non-sterile, non-measuring Class A devices only require self-notification on the SUGAM portal. Sterile or measuring Class A devices must undergo full CDSCO review via Form MD-14.

Class B — Low-Moderate Risk
Class B Devices

Low-moderate risk devices such as hypodermic needles, surgical gloves, powered wheelchairs, and blood administration sets. Requires CDSCO review and approval.

What testing is needed for Class B?

Class B devices require performance testing, biocompatibility assessment (if applicable), and ISO 13485 QMS certification. Test reports must be from NABL/ISO 17025 accredited labs.

Class C — Moderate-High Risk
Class C Devices

Moderate-high risk devices including ventilators, dialysis machines, infusion pumps, and bone fixation plates. Requires detailed clinical evidence and CDSCO expert committee review.

Is clinical data required for Class C?

Yes. Class C devices require clinical evidence demonstrating safety and performance. This may include clinical investigation data, published literature, or equivalent device comparisons per MDR 2017 Schedule V.

Class D — Highest Risk
Class D Devices

Highest-risk devices including cardiac stents, implantable defibrillators, heart valves, and hip implants. Subject to the most rigorous CDSCO review and may require Indian clinical trials.

Do Class D devices need Indian clinical trials?

Class D devices may require clinical investigations conducted in India, depending on the device type and available global clinical evidence. CDSCO can waive this requirement based on risk-benefit assessment and data from stringent regulatory authorities.

Our CDSCO Services

Comprehensive CDSCO Registration Services

From initial classification through post-market surveillance, NexorTest manages every aspect of your CDSCO regulatory journey.

CDSCO Class A/B Registration

Complete Form MD-14 preparation and submission for low and low-moderate risk devices. Includes self-notification management for non-sterile, non-measuring Class A devices and full CDSCO review support for Class B.

CDSCO Class C/D Registration

End-to-end Form MD-15 management for moderate-high and highest-risk devices. Includes clinical evidence compilation, expert committee preparation, query resolution, and manufacturing/import license acquisition.

SUGAM Portal Submission

Expert management of the entire SUGAM portal (cdscoonline.gov.in) workflow including account setup, document uploads, fee payments, application tracking, and query response management.

BIS Certification

Bureau of Indian Standards certification for notified medical device categories. Includes product testing at BIS-recognized labs, factory inspection coordination, and ISI mark license acquisition for mandatory compliance.

ISO 13485 QMS Implementation

Full implementation of ISO 13485 Quality Management System required for CDSCO registration. Gap analysis, documentation development, internal audit support, and certification body coordination.

IVD Registration India

Specialized In Vitro Diagnostic device registration covering IVD-specific risk classification, analytical and clinical performance evaluation, reagent documentation, and CDSCO submission for all IVD categories.

SaMD Regulatory Pathway

Software as a Medical Device regulatory strategy for India. Covers software lifecycle documentation (IEC 62304), cybersecurity risk assessments, AI/ML validation, and CDSCO's evolving digital health requirements.

Import & Manufacturing License

Acquisition of import licenses for foreign manufacturers and manufacturing licenses for Indian producers. Includes authorized agent appointment, factory inspection preparation, and license maintenance with 5-year retention fees.

Post-Market Surveillance

Comprehensive post-market surveillance and vigilance reporting systems. Includes adverse event reporting to CDSCO, periodic safety update reports (PSURs), field safety corrective actions, and regulatory compliance monitoring.

Why NexorTest

India's Trusted CDSCO Specialist

We combine deep local regulatory expertise with global experience to deliver faster, more predictable CDSCO approvals.

India's Leading CDSCO Specialist

Local regulatory team with direct experience navigating CDSCO processes, state drug controllers, and SUGAM portal intricacies. We know the system inside and out.

Design + Testing + Certification Under One Roof

Integrated services covering product design review, safety and performance testing at our own accredited labs, and complete regulatory certification — eliminating multi-vendor complexity.

ISO/IEC 17025 Accredited Testing Labs in India

NABL-accredited laboratories in India for electrical safety (IEC 60601), EMC, biocompatibility (ISO 10993), and performance testing — reducing turnaround time and logistics costs.

Multi-Region Regulatory Expertise

Simultaneous registrations across CDSCO, US FDA, EU MDR/CE, Saudi SFDA, and TGA Australia. One partner for global market access from a single integrated program.

Transparent Pricing & Fixed-Fee Packages

No hidden costs or hourly billing surprises. Our fixed-fee packages cover the complete scope from strategy through license issuance, with clear milestones and deliverables.

CDSCO Registrations Completed
0 +
First-Pass Approval Rate
0 %
Years Regulatory Experience
0 +
Active Clients Worldwide
0 +
Regulatory Markets Served
0 +
Faster Than Industry Average
0 %
Our Process

Six Steps to Your CDSCO License

A proven, structured approach that minimizes review queries and accelerates your path to the Indian medical device market.

1
Device Classification & Regulatory Strategy

We determine your device’s risk classification (Class A, B, C, or D) under MDR 2017 and develop a tailored regulatory strategy including applicable Indian standards, testing requirements, and the optimal submission pathway.

2
Documentation & Technical File Preparation

Our team prepares the complete technical documentation including device master file, risk analysis (ISO 14971), essential principles checklist, biocompatibility data, labeling, and IFU per CDSCO requirements.

3
Testing at ISO/IEC 17025 Accredited Labs

We conduct all required safety, performance, and biocompatibility testing at our NABL and ISO/IEC 17025 accredited laboratories in India, including IEC 60601 electrical safety, EMC, and ISO 10993 testing.

4
SUGAM Portal Application Submission

We submit the completed application via CDSCO’s SUGAM portal using Form MD-14 (Class A/B) or Form MD-15 (Class C/D), with all supporting documentation, test reports, and applicable government fees.

5
CDSCO Review & Query Resolution

We manage the entire review cycle, respond to technical queries and deficiency notices promptly, coordinate with CDSCO reviewers, and facilitate expert committee presentations when required for Class C/D devices.

6
License Issuance & Post-Market Compliance

Upon approval, we secure your perpetual manufacturing or import license, set up post-market surveillance and vigilance reporting systems, and manage ongoing 5-year retention fee renewals and regulatory updates.

Industries We Serve

CDSCO Registration Across All Device Sectors

NexorTest supports medical device manufacturers across every therapeutic area and technology vertical entering the Indian market.

Frequently Asked Questions

CDSCO Registration FAQ

Expert answers to the most common questions about medical device registration with CDSCO India.

CDSCO medical device registration is the mandatory regulatory process governed by the Central Drugs Standard Control Organisation under India’s Ministry of Health & Family Welfare. Under the Medical Device Rules (MDR) 2017, all medical devices manufactured in or imported into India must be registered with CDSCO before marketing. The process involves device classification (Class A through D), documentation preparation, testing at accredited labs, and application submission via the SUGAM portal (cdscoonline.gov.in). Registration results in a manufacturing or import license that is now perpetual, subject to 5-year retention fees.

To apply for CDSCO registration via the SUGAM portal (cdscoonline.gov.in): (1) Register an account on the SUGAM portal. (2) Determine your device classification (A, B, C, or D). (3) Prepare the required technical documentation and test reports. (4) Submit Form MD-14 for Class A/B devices or Form MD-15 for Class C/D devices. (5) Pay the applicable fees online. (6) Track your application status through the portal. (7) Respond to any queries raised by CDSCO reviewers. The portal supports online tracking, auto-generated compliance certificates, and digital license issuance.

CDSCO Class C/D registration via Form MD-15 requires: device master file including design and manufacturing details, risk analysis report (ISO 14971), essential principles checklist, biocompatibility test reports (ISO 10993), electrical safety reports (IEC 60601 if applicable), software validation documentation for SaMD, clinical investigation reports or clinical evidence, ISO 13485 QMS certificate, labeling and IFU, shelf-life or stability data, free sale certificate from country of origin (for imports), and authorized Indian agent documentation. All test reports must come from ISO/IEC 17025 accredited laboratories.

CDSCO medical device registration costs include government fees and professional consulting fees. Government application fees range from INR 5,000 for Class A devices to INR 50,000 for Class D devices. Testing costs at accredited labs vary significantly based on device type and required standards (ISO 10993, IEC 60601, etc.). Professional consulting fees depend on device complexity, classification, and scope of services. NexorTest offers transparent fixed-fee packages covering regulatory strategy, documentation, testing coordination, SUGAM portal submission, and post-market compliance support. Contact us for a free cost assessment.

CDSCO classifies medical devices into four risk-based classes under MDR 2017. Class A represents low-risk devices such as tongue depressors and bandages. Class B covers low-moderate risk devices like hypodermic needles and surgical gloves. Class C includes moderate-high risk devices such as ventilators and dialysis machines. Class D encompasses the highest-risk devices including cardiac stents and implantable defibrillators. As of 2025-2026, CDSCO has reclassified 553 devices under a risk-based framework. Class A non-sterile, non-measuring devices can be self-notified, while all other classes require CDSCO review.

CDSCO registration timelines vary by device class. Class A non-sterile, non-measuring devices can be self-notified within 1-2 weeks. Class A (sterile/measuring) and Class B devices typically take 3-6 months via Form MD-14. Class C devices generally require 6-9 months, while Class D devices may take 9-15 months via Form MD-15. Timelines depend on documentation completeness, testing requirements, and CDSCO query response cycles. NexorTest’s regulatory experts help streamline the process by ensuring complete submissions that minimize review queries.

BIS (Bureau of Indian Standards) certification is mandatory for specific categories of medical devices notified by the Indian government under compulsory registration orders. Currently, devices such as cardiac stents, condoms, surgical gloves, and certain electronic medical equipment require BIS certification in addition to CDSCO registration. BIS certification involves product testing at BIS-recognized labs, factory inspection, and grant of ISI mark license. NexorTest assists manufacturers with both CDSCO registration and BIS certification to ensure complete regulatory compliance in India.

Yes, NexorTest provides specialized CDSCO registration services for In Vitro Diagnostic (IVD) devices and Software as a Medical Device (SaMD). For IVDs, we handle classification under IVD-specific risk categories, performance evaluation studies, analytical and clinical evidence compilation, and SUGAM portal submissions. For SaMD, we manage software lifecycle documentation per IEC 62304, cybersecurity risk assessments, clinical evidence for AI/ML-based devices, and regulatory strategy aligned with India’s evolving digital health framework. Our team has extensive experience navigating CDSCO’s review processes for both IVD and SaMD categories.

Ready to Enter the Indian Medical Device Market?

Get a free CDSCO regulatory assessment from India’s leading medical device registration consultants. Our experts will map your fastest path to market.

Accreditations & Certifications

ISO/IEC 17025

Accredited Labs

ISO 13485

QMS Certified

NABL

National Accreditation

BIS

Bureau of Indian Standards

CDSCO

Recognised Consultant

Global Regulatory Services

Expand Beyond India with Multi-Market Access

Leverage NexorTest's global regulatory network to register your medical device in 40+ markets from a single integrated program.

US FDA 510(k)
EU MDR CE Marking
EU IVDR
UK UKCA / MHRA
Saudi SFDA
UAE MoHAP
TGA Australia
Africa SAHPRA / NAFDAC
Scroll to Top